-
FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions.
-
-
In an analysis of community-performed colonoscopies in southwestern Germany, the prevalence of left-sided advanced colorectal neoplasms, but not right-sided neoplasms, was strongly reduced within a ten-year period after colonoscopy.
-
The patient is an 82-year-old woman referred for management of newly diagnosed breast cancer. She had been well until approximately 10 years prior to this evaluation, when she sustained a myocardial infarction from which she recovered without complication. Subsequently, she was found to have moderate hypertension and hyperlipidemia, which has been managed medically.
-
The activation mutation JAK2 tyrosine kinase (JAK2V617F) is found in 50% of patients with myleofibrosis (MF). In this phase-2 study, CEP 701, a JAK2 inhibitor, was administered to MF patients harboring a JAK2 mutation.
-
The seven-year update of IRIS (a phase-3 International Randomized Study of Interferon and STI571), which randomized chronic-phase CML (CP-CML) patients to IFNa/AraC or imatinib (400 mg/d), showed an 81% EFS and 86% OS for imantinib.
-
-
The Current Procedural Terminology (CPT) code changes in place in the 2008 Physician Fee Schedule improve the ability of physicians and other providers to document their telephone evaluations and management services, but they don't go far enough, according to the Case Management Society of America (CMSA).
-
A new survey, conducted by a worldwide company that provides private, in-home care for older adults, suggests that older Americans and their adult children do a poor job of planning for their future needs as health begins to fail.
-
What hospitalists and others involved in the discharge process truly want to do is reduce patients' risk at discharge while implementing quality improvement (QI) initiatives with limited resources.